Elevated tRNAiMet Synthesis Can Drive Cell Proliferation and Oncogenic Transformation

Cell

Volumn 133, Issue 1, 2008, Pages 78-89

  Marshall, Lynne ^a,b   Kenneth, Niall S ^a   White, Robert J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

CELLBIO; CELLCYCLE; PROTEINS

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRF1; TRANSFER RNA; UNCLASSIFIED DRUG; DNA DIRECTED RNA POLYMERASE III; METHIONINE TRANSFER RNA; TRANSCRIPTION FACTOR IIIB;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; IMMUNOBLOTTING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; ANIMAL; CELL CYCLE; CELL STRAIN 3T3; CHO CELL; CRICETULUS; CYTOLOGY; FIBROBLAST; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; HUMAN; METABOLISM; TUMOR CELL LINE;

MUS;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHO CELLS; CRICETINAE; CRICETULUS; FIBROBLASTS; HUMANS; MICE; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; RNA POLYMERASE III; RNA, TRANSFER, MET; TRANSCRIPTION FACTOR TFIIIB; TRANSCRIPTION, GENETIC;

EID: 41349089950     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.02.035     Document Type: Article

References (57)

1. Anand N., Murthy S., Amann G., Wernick M., Porter L.A., Cukier I.W., Collins C., Gray J.W., Diebold J., Demetrick D.J., and Lee J.M. Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31 (2002) 301-305
2. Bjornsti M.-A., and Houghton P.J. Lost in translation: dysregulation of cap-dependent translation and cancer. Cancer Cell 5 (2004) 519-523
3. Brooks R.F. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12 (1977) 311-317
4. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
5. Cairns C.A., and White R.J. p53 is a general repressor of RNA polymerase III transcription. EMBO J. 17 (1998) 3112-3123
6. Chu W.-M., Wang Z., Roeder R.G., and Schmid C.W. RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. J. Biol. Chem. 272 (1997) 14755-14761
7. Crighton D., Woiwode A., Zhang C., Mandavia N., Morton J.P., Warnock L.J., Milner J., White R.J., and Johnson D.L. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 22 (2003) 2810-2820
8. Daly N.L., Arvanitis D.A., Fairley J.A., Gomez-Roman N., Morton J.P., Graham S.V., Spandidos D.A., and White R.J. Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus. Oncogene 24 (2005) 880-888
9. Daniels G.R., and Deininger P.L. Repeat sequence families derived from mammalian tRNA genes. Nature 317 (1985) 819-822
10. Donze O., Jagus R., Koromilas A.E., Hershey J.W.B., and Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14 (1995) 3828-3834
11. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348
12. Fairley J.A., Scott P.H., and White R.J. TFIIIB is phosphorylated, disrupted and selectively released from tRNA promoters during mitosis in vivo. EMBO J. 22 (2003) 5841-5850
13. Fairley J.A., Kantidakis T., Kenneth N.S., Intine R.V., Maraia R., and White R.J. Human La is found at RNA polymerase III-transcribed genes in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 18350-18355
14. Felton-Edkins Z.A., and White R.J. Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. J. Biol. Chem. 277 (2002) 48182-48191
15. Felton-Edkins Z.A., Fairley J.A., Graham E.L., Johnston I.M., White R.J., and Scott P.H. The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB. EMBO J. 22 (2003) 2422-2432
16. Felton-Edkins Z.A., Kenneth N.S., Brown T.R.P., Daly N.L., Gomez-Roman N., Grandori C., Eisenman R.N., and White R.J. Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 3 (2003) 181-184
17. Felton-Edkins Z.A., Kondrashov A., Karali D., Fairley J.A., Dawson C.W., Arrand J.R., Young L.S., and White R.J. Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J. Biol. Chem. 281 (2006) 33871-33880
18. Francis M.A., and Rajbhandary U.L. Expression and function of a human initiator tRNA gene in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 10 (1990) 4486-4494
19. Frye M., and Watt F.M. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumours. Curr. Biol. 16 (2006) 971-981
20. Gomez-Roman N., Grandori C., Eisenman R.N., and White R.J. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421 (2003) 290-294
21. Goodfellow S.J., Innes F., Derblay L.E., MacLellan W.R., Scott P.H., and White R.J. Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J. 25 (2006) 1522-1533
22. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
23. Hirsch H.A., Jawdekar G.W., Lee K.-A., Gu L., and Henry R.W. Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein. Mol. Cell. Biol. 24 (2004) 5989-5999
24. Hurford R.K., Cobrinik D., Lee M.-H., and Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11 (1997) 1447-1463
25. Johnston G.C., Pringle J.R., and Hartwell L.H. Coordination of growth with cell division in the yeast Saccharomyces cerevisiae. Exp. Cell Res. 105 (1977) 79-98
26. Jones E., Kimura H., Vigneron M., Wang Z., Roeder R.G., and Cook P.R. Isolation and characterization of monoclonal antibodies directed against subunits of human RNA polymerases I, II and III. Exp. Cell Res. 254 (2000) 163-172
27. Kassavetis G.A., Braun B.R., Nguyen L.H., and Geiduschek E.P. S. cerevisiae TFIIIB is the transcription initiation factor proper of RNA polymerase III, while TFIIIA and TFIIIC are assembly factors. Cell 60 (1990) 235-245
28. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
29. Koromilas A.E., Lazaris-Karatzas A., and Sonenberg N. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J. 11 (1992) 4153-4158
30. Larminie C.G.C., Cairns C.A., Mital R., Martin K., Kouzarides T., Jackson S.P., and White R.J. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16 (1997) 2061-2071
31. Larminie C.G.C., Alzuherri H.M., Cairns C.A., McLees A., and White R.J. Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein. J. Mol. Med. 76 (1998) 94-103
32. Larminie C.G.C., Sutcliffe J.E., Tosh K., Winter A.G., Felton-Edkins Z.A., and White R.J. Activation of RNA polymerase III transcription in cells transformed by simian virus 40. Mol. Cell. Biol. 19 (1999) 4927-4934
33. Lazaris-Karatzas A., Montine K.S., and Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345 (1990) 544-546
34. Mamane Y., Petroulakis E., Rong L., Yoshida K., Wee Ler L., and Sonenberg N. eIF4E-from translation to transformation. Oncogene 23 (2004) 3172-3179
35. Mayeur G.L., and Hershey J.W.B. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514 (2002) 49-54
36. Morton J.P., Kantidakis T., and White R.J. RNA polymerase III transcription is repressed in response to the tumour suppressor ARF. Nucleic Acids Res. 35 (2007) 3046-3052
37. Nasmyth K. Another role rolls in. Nature 382 (1996) 28-29
38. Neufeld T.P., and Edgar B.A. Connections between growth and the cell cycle. Curr. Opin. Cell Biol. 10 (1998) 784-790
39. Pandolfi P.P. Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age. Oncogene 23 (2004) 3134-3137
40. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
41. Ruggero D., and Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev. Cancer 3 (2003) 179-192
42. Sansom O.J., Meniel V.S., Muncan V., Phesse T.J., Wilkins J.A., Reed K.R., Vass J.K., Athineos D., Clevers H., and Clarke A.R. Myc deletion rescues Apc deficiency in the small intestine. Nature 446 (2007) 676-679
43. Schramm L., and Hernandez N. Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16 (2002) 2593-2620
44. Schramm L., Pendergrast P.S., Sun Y., and Hernandez N. Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev. 14 (2000) 2650-2663
45. Scott P.H., Cairns C.A., Sutcliffe J.E., Alzuherri H.M., Mclees A., Winter A.G., and White R.J. Regulation of RNA polymerase III transcription during cell cycle entry. J. Biol. Chem. 276 (2001) 1005-1014
46. Stein T., Crighton D., Boyle J.M., Varley J.M., and White R.J. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome. Oncogene 21 (2002) 2961-2970
47. Stocker H., and Hafen E. Genetic control of cell size. Curr. Opin. Genet. Dev. 10 (2000) 529-535
48. Sudbery P. When wee meets whi. Science 297 (2002) 351-352
49. Sutcliffe J.E., Cairns C.A., McLees A., Allison S.J., Tosh K., and White R.J. RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130. Mol. Cell. Biol. 19 (1999) 4255-4261
50. Tatsuka M., Mitsui H., Wada M., Nagata A., Nojima H., and Okayama H. Elongation factor-1α gene determines susceptibility to transformation. Nature 359 (1992) 333-335
51. Tomlinson V.A.L., Newbury H.J., Wray N.R., Jackson J., Larionov A., Miller W.R., Dixon J.M., and Abbott C.M. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 5 (2005) 113
52. White R.J. RNA polymerase III transcription and cancer. Oncogene 23 (2004) 3208-3216
53. White R.J. RNA polymerases I and III, growth control and cancer. Nat. Rev. Mol. Cell Biol. 6 (2005) 69-78
54. White R.J., Gottlieb T.M., Downes C.S., and Jackson S.P. Mitotic regulation of a TATA-binding-protein-containing complex. Mol. Cell. Biol. 15 (1995) 1983-1992
55. White R.J., Trouche D., Martin K., Jackson S.P., and Kouzarides T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382 (1996) 88-90
56. Winter A.G., Sourvinos G., Allison S.J., Tosh K., Scott P.H., Spandidos D.A., and White R.J. RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumours. Proc. Natl. Acad. Sci. USA 97 (2000) 12619-12624
57. Zetterberg A., and Killander D. Quantitative cytophotometric and autoradiographic studies on the rate of protein synthesis during interphase in mouse fibroblasts in vitro. Exp. Cell Res. 40 (1965) 1-11